Posted by Michael Wonder on 16 Jan 2022
COVID-19 vaccine weekly safety report (6 January 2022)
17 January 2022 - To 2 January 2022, the TGA has received 415 reports which have been assessed as likely to be myocarditis from about 27.3 million doses of Comirnaty (Pfizer) and 40 reports which have been assessed as likely to be myocarditis from about 1.8 million doses of Spikevax (Moderna).
No new cases of probable thrombosis with thrombocytopenia syndrome were reported the past two weeks.
